60 Degrees Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $135 | $125 | $146 | $42 |
Gross Profit | 23 | 36 | 80 | -103 |
EBITDA | -2,144 | -4,159 | 451 | -1,870 |
EBIT | -2,158 | -4,170 | 429 | -1,894 |
Net Income | -2,159 | -4,172 | 430 | -1,958 |
Net Change In Cash | 135 | 125 | 146 | 42 |
Free Cash Flow | 2,469 | -1,318 | -1,150 | -130 |
Cash | 3,300 | 1,576 | 2,894 | 2,142 |
Basic Shares | 2,443 | 1,014 | 10,124 | 5,810 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $253 | $223 | $1,160 | $2,181 |
Gross Profit | -220 | -209 | 309 | 1,478 |
EBITDA | -1,426 | -2,109 | -1,014 | -341 |
EBIT | -1,526 | -2,187 | -1,086 | -369 |
Net Income | -3,765 | -6,181 | -4,251 | -3,033 |
Net Change In Cash | 253 | 223 | 1,160 | 2,181 |
Free Cash Flow | -4,658 | -1,070 | -684 | -238 |
Cash | 2,142 | 264 | 115 | 191 |
Basic Shares | 3,960 | 5,781 | 5,781 | 5,781 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$4.33 |
2024-06-30 | -$20.55 |
2024-03-31 | $0.03 |
2023-12-31 | -$0.35 |
